Quick Answer
Equillium, Inc. reported Revenue (ASC 606) of $41.09 million for fiscal year 2024.
Equillium, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2024 | $41.09M | +13.9% |
| 2023 | $36.08M | +129.0% |
| 2022 | $15.76M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $12.16M | +37.1% | -12.2% |
| June 30, 2024 | $13.85M | +51.8% | +29.6% |
| March 31, 2024 | $10.69M | +20.4% | +20.5% |
| September 30, 2023 | $8.87M | — | -2.8% |
| June 30, 2023 | $9.12M | — | +2.8% |
| March 31, 2023 | $8.88M | — | — |
- Equillium, Inc. showed an increase of +13.9% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2022–2024 period, Equillium, Inc.’s revenue (asc 606) has grown by 160.8% (from $15.76 million to $41.09 million).
- The most recent figure is from Equillium, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: